149 related articles for article (PubMed ID: 25693499)
1. Target-based whole-cell screening by ¹H NMR spectroscopy.
Ma J; Cao Q; McLeod SM; Ferguson K; Gao N; Breeze AL; Hu J
Angew Chem Int Ed Engl; 2015 Apr; 54(16):4764-7. PubMed ID: 25693499
[TBL] [Abstract][Full Text] [Related]
2. Real-time monitoring of New Delhi metallo-β-lactamase activity in living bacterial cells by 1H NMR spectroscopy.
Ma J; McLeod S; MacCormack K; Sriram S; Gao N; Breeze AL; Hu J
Angew Chem Int Ed Engl; 2014 Feb; 53(8):2130-3. PubMed ID: 24458501
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor discovery of full-length New Delhi metallo-β-lactamase-1 (NDM-1).
Shen B; Yu Y; Chen H; Cao X; Lao X; Fang Y; Shi Y; Chen J; Zheng H
PLoS One; 2013; 8(5):e62955. PubMed ID: 23675445
[TBL] [Abstract][Full Text] [Related]
4. Fluorinated captopril analogues inhibit metallo-β-lactamases and facilitate structure determination of NDM-1 binding pose.
Kondratieva A; Palica K; Frøhlich C; Hovd RR; Leiros HS; Erdelyi M; Bayer A
Eur J Med Chem; 2024 Feb; 266():116140. PubMed ID: 38242072
[TBL] [Abstract][Full Text] [Related]
5. Pterostilbene restores carbapenem susceptibility in New Delhi metallo-β-lactamase-producing isolates by inhibiting the activity of New Delhi metallo-β-lactamases.
Liu S; Zhang J; Zhou Y; Hu N; Li J; Wang Y; Niu X; Deng X; Wang J
Br J Pharmacol; 2019 Dec; 176(23):4548-4557. PubMed ID: 31376166
[TBL] [Abstract][Full Text] [Related]
6. The activity and mechanism of vidofludimus as a potent enzyme inhibitor against NDM-1-positive E. coli.
Li X; Zhao D; Zhao X; Cheng P; Li F; Sun J; Li Y; Bai J; Zhang X
Eur J Med Chem; 2023 Mar; 250():115225. PubMed ID: 36870273
[TBL] [Abstract][Full Text] [Related]
7. On the Offensive: the Role of Outer Membrane Vesicles in the Successful Dissemination of New Delhi Metallo-β-lactamase (NDM-1).
Martínez MMB; Bonomo RA; Vila AJ; Maffía PC; González LJ
mBio; 2021 Oct; 12(5):e0183621. PubMed ID: 34579567
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel new Delhi metallo-β-lactamases-1 inhibitors by multistep virtual screening.
Wang X; Lu M; Shi Y; Ou Y; Cheng X
PLoS One; 2015; 10(3):e0118290. PubMed ID: 25734558
[TBL] [Abstract][Full Text] [Related]
9. Real-Time Monitoring of NDM-1 Activity in Live Bacterial Cells by Isothermal Titration Calorimetry: A New Approach To Measure Inhibition of Antibiotic-Resistant Bacteria.
Zhang YJ; Wang WM; Oelschlaeger P; Chen C; Lei JE; Lv M; Yang KW
ACS Infect Dis; 2018 Dec; 4(12):1671-1678. PubMed ID: 30383355
[TBL] [Abstract][Full Text] [Related]
10. Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
Guo Y; Yang Y; Xu X; Li L; Zhou Y; Jia G; Wei L; Yu Q; Wang J
Eur J Med Chem; 2022 Mar; 231():114108. PubMed ID: 35101651
[TBL] [Abstract][Full Text] [Related]
11. A molecular dynamics study of the complete binding process of meropenem to New Delhi metallo-β-lactamase 1.
Duan J; Hu C; Guo J; Guo L; Sun J; Zhao Z
Phys Chem Chem Phys; 2018 Feb; 20(9):6409-6420. PubMed ID: 29442101
[TBL] [Abstract][Full Text] [Related]
12. A quantum mechanics/molecular mechanics study on the hydrolysis mechanism of New Delhi metallo-β-lactamase-1.
Zhu K; Lu J; Liang Z; Kong X; Ye F; Jin L; Geng H; Chen Y; Zheng M; Jiang H; Li JQ; Luo C
J Comput Aided Mol Des; 2013 Mar; 27(3):247-56. PubMed ID: 23456591
[TBL] [Abstract][Full Text] [Related]
13. Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors.
Li JQ; Sun LY; Jiang Z; Chen C; Gao H; Chigan JZ; Ding HH; Yang KW
Bioorg Chem; 2021 Feb; 107():104576. PubMed ID: 33383326
[TBL] [Abstract][Full Text] [Related]
14. Monitoring conformational changes in the NDM-1 metallo-β-lactamase by 19F NMR spectroscopy.
Rydzik AM; Brem J; van Berkel SS; Pfeffer I; Makena A; Claridge TD; Schofield CJ
Angew Chem Int Ed Engl; 2014 Mar; 53(12):3129-33. PubMed ID: 24615874
[TBL] [Abstract][Full Text] [Related]
15. Ebselen as a potent covalent inhibitor of New Delhi metallo-β-lactamase (NDM-1).
Chiou J; Wan S; Chan KF; So PK; He D; Chan EW; Chan TH; Wong KY; Tao J; Chen S
Chem Commun (Camb); 2015 Jun; 51(46):9543-6. PubMed ID: 25970101
[TBL] [Abstract][Full Text] [Related]
16. Benzimidazole and Benzoxazole Zinc Chelators as Inhibitors of Metallo-β-Lactamase NDM-1.
Jackson AC; Pinter TBJ; Talley DC; Baker-Agha A; Patel D; Smith PJ; Franz KJ
ChemMedChem; 2021 Feb; 16(4):654-661. PubMed ID: 33211374
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of NDM-1-catalyzed carbapenem hydrolysis is distinct from that of penicillin or cephalosporin hydrolysis.
Feng H; Liu X; Wang S; Fleming J; Wang DC; Liu W
Nat Commun; 2017 Dec; 8(1):2242. PubMed ID: 29269938
[TBL] [Abstract][Full Text] [Related]
18. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
Muteeb G; Alsultan A; Farhan M; Aatif M
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073
[TBL] [Abstract][Full Text] [Related]
19. Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.
Chen AY; Thomas PW; Stewart AC; Bergstrom A; Cheng Z; Miller C; Bethel CR; Marshall SH; Credille CV; Riley CL; Page RC; Bonomo RA; Crowder MW; Tierney DL; Fast W; Cohen SM
J Med Chem; 2017 Sep; 60(17):7267-7283. PubMed ID: 28809565
[TBL] [Abstract][Full Text] [Related]
20. Structural insight into mode of binding of Meropenem to CTX-M-15 type β-lactamase.
Maryam L; Khan AU
Int J Biol Macromol; 2017 Mar; 96():78-86. PubMed ID: 27986632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
